Treatment for refractory seizures

Israel’s Teva has launched a generic version of Sabril (vigabatrin) in the US for the treatment of refractory Complex Partial Seizures (CPS). It is meant for adults and children over 10 with this form of epilepsy who have failed to respond to several alternative treatments.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *